Home›Research›Compare›Angiotensin (1-7) vs MOTS-c
Peptide ComparisonAngiotensin (1-7) vs MOTS-c
Both are Longevity & Cellular peptides.
Angiotensin (1-7)
Ang-(1-7)
Half-life: ~9–10 sec (rat)
No providers listed yet
MOTS-c
Mitochondrial ORF of the 12S rRNA type-c
Half-life: Unknown (rapidly cleared from plasma)
185 providers listed
Angiotensin (1-7) carries stronger published evidence (RCT, 9 key studies) than MOTS-c (Cohort study, 8); both are research compounds.
Angiotensin (1-7)
Half-life
~9–10 sec (rat)
MOTS-c
Half-life
Unknown (rapidly cleared from plasma)
| Your goal | Better option |
|---|---|
| Stronger clinical evidence | Angiotensin (1-7) |
| Further along in FDA review | Angiotensin (1-7) |
| More provider options (0 vs 185) | MOTS-c |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
Angiotensin (1-7)
MOTS-c
Angiotensin (1-7)
Association between renin angiotensin system and cognitive outcomes over 15 years: The Look AHEAD study.
Angiotensin-(1-7) improves oxygenation in mechanically ventilated COVID-19 patients: a randomized phase 1-2 s…
Perioperative Angiotensin-(1-7) for Postoperative Cognitive Vulnerability Following Coronary Artery Bypass Su…
The Effect of Angiotensin (1-7) on Serum Metabolomics in Obese Type 2 Diabetic Mice.
+5 more
MOTS-c
Reduced Circulating MOTS-c Levels in Hashimoto's Thyroiditis Reflect Integrated Autoimmune and Metabolic Dysr…
Humanin and MOTS-c Attenuate Atrial Fibrillation by Suppressing Fibrosis and Mitochondrial Dysfunction.
LAT1-mediated delivery of engineered R13A-MOTS-c attenuates radiation-induced lung injury via Nrf2 activation…
MOTS-c attenuates hyperoxia-induced neonatal cardiac injury by inhibiting oxeiptosis via maintaining the KEAP…
+4 more
About Angiotensin (1-7)
Binds Mas receptor (MasR), activating nitric oxide synthase and reducing oxidative stress. Opposes TGF-β and angiotensin II signaling to reduce fibrosis. Enhances insulin sensitivity and provides cardiovascular protection.
About MOTS-c
Mitochondria-derived peptide that translocates to nucleus under stress; activates AMPK pathway, regulates AICAR and folate-methionine cycle
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
Angiotensin (1-7)
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
MOTS-c
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
Angiotensin (1-7)
Not enough vendor pricing yet.
MOTS-c
Where to source these peptides
Angiotensin (1-7)
Browse directory →
Providers offeringMOTS-c
185 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More Longevity & Cellular Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated August 26, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). Angiotensin (1-7) vs MOTS-c — Per-mg Price Comparison. Retrieved September 11, 2026, from https://peptidebase.io/peptides/compare/angiotensin-1-7/mots-c